Morphological Predictors of Sudden Cardiac Death in Patients With Known Cardiomyopathies
NCT ID: NCT00312624
Last Updated: 2011-06-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2006-04-30
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Left Ventricular Structural Predictors of Sudden Cardiac Death
NCT01076660
Imaging Techniques for Identifying Factors of Sudden Cardiac Death Risk
NCT00181233
Sudden Death Stratification
NCT04607265
Pathogenesis of Stress-Induced Cardiomyopathy by I-123 MIBG
NCT01432626
Prediction of Sudden Cardiac Death in Dilated Cardiomyopathy
NCT03224156
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
contrast-enhanced cardiac MRI
MRI of heart with delayed enhancement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* cardiomyopathy with LVEF 35% or less
* indication for ICD implantation
* able to provide informed consent
Exclusion Criteria
* contraindication for MRI (i.e., metallic foreign body)
* claustrophobia
* pregnant women
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pittsburgh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
UPMC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Samir Saba, MD
Role: PRINCIPAL_INVESTIGATOR
University of Pittsburgh
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0602085
Identifier Type: -
Identifier Source: secondary_id
0602085
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.